KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Capital Expenditures (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Capital Expenditures for 6 consecutive years, with $692000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Capital Expenditures rose 73.43% year-over-year to $692000.0, compared with a TTM value of $1.8 million through Sep 2025, up 80.25%, and an annual FY2024 reading of $1.6 million, up 166.44% over the prior year.
  • Capital Expenditures was $692000.0 for Q3 2025 at Clover Health Investments, up from $569000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $3.9 million in Q4 2022 and bottomed at -$264000.0 in Q4 2023.
  • Average Capital Expenditures over 5 years is $461894.7, with a median of $251000.0 recorded in 2023.
  • The sharpest move saw Capital Expenditures soared 1528.99% in 2022, then plummeted 106.81% in 2023.
  • Year by year, Capital Expenditures stood at $238000.0 in 2021, then skyrocketed by 1528.99% to $3.9 million in 2022, then tumbled by 106.81% to -$264000.0 in 2023, then soared by 219.32% to $315000.0 in 2024, then skyrocketed by 119.68% to $692000.0 in 2025.
  • Business Quant data shows Capital Expenditures for CLOV at $692000.0 in Q3 2025, $569000.0 in Q2 2025, and $185000.0 in Q1 2025.